The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Fatal Familial Insomnia and Familial Creutzfeldt-Jakob Disease: Disease Phenotype Determined by a DNA Polymorphism
Abstract
Fatal familial insomnia (FFI) and a subtype of familial Creutzfeldt-Jakob disease (CJD), two clinically and pathologically distinct diseases, are linked to the same mutation at codon 178 (Asn 178 ) of the prion protein gene. The possibility that a second genetic component modified the phenotypic expression of the Asn 178 mutation was investigated. FFI and the familial CJD subtype segregated with different genotypes determined by the Asn 178 mutation and the methionine-valine polymorphism at codon 129. The Met 129 , Asn 178 allele segregated with FFI in all 15 affected members of five kindreds whereas the Val 129 , Asn 178 allele segregated with the familial CJD subtype in all 15 affected members of six kindreds. Thus, two distinct disease phenotypes linked to a single pathogenic mutation can be determined by a common polymorphism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Molecular Biology of Prion Diseases
Prusiner, S. B. (1991) · Science · doi:10.1126/science.1675487 · Cited by 1,988
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease
Palmer, M. S., Dryden, A. J., Hughes, J. T., & Collinge, J. (1991) · Nature · doi:10.1038/352340a0 · Cited by 890
Hendriks, L., van Duijn, C. M., Cras, P., Cruts, M., Van Hul, W., van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., Martin, J.-J., et al. (1992) · Nature Genetics · doi:10.1038/ng0692-218 · Cited by 734
Fatal Familial Insomnia, a Prion Disease with a Mutation at Codon 178 of the Prion Protein Gene
Medori, R., Tritschler, H.-J., LeBlanc, A., Villare, F., Manetto, V., Chen, H. Y., Xue, R., Leal, S., Montagna, P., Cortelli, P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202133260704 · Cited by 606
Self-citationGenetic predisposition to iatrogenic Creutzfeldt-Jakob disease
Collinge, J., Palmer, M. S., & Dryden, A. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)93128-v · Cited by 556
MASTERS, C. L., GAJDUSEK, D. C., & GIBBS, C. J. (1981) · Brain · doi:10.1093/brain/104.3.559 · Cited by 527
Self-citation
Research works printed but not linked: 10
- BUGE, A, FAMILIAL CREUTZFELDT-JAKOB DISEASE - CLINICAL AND PATHOLOGICAL-STUDY OF 3 CASES IN A FAMILY WITH 8 AFFECTED MEMBERS IN 3 GENERATIONS, REVUE NEUROLOGIQUE 134: 165 (1978).
- GOLDFARB, L.G., Patients with Creutzfeldt-Jakob disease and kuru lack the mutation in the PRIP gene found in Gerstmann-Straussler syndrome, but they show a different double-allele mutation in the same gene, AMERICAN JOURNAL OF HUMAN GENETICS 45 Supplement: A189 (1989).
- GOOSSENS, M, HEMOGLOBIN C ZIGUINCHOR ALPHA A2 BETA-62 (A3) GLU-]VALBETA-58 (E2) PRO-]ARG - 2ND SICKLING VARIANT WITH AMINO-ACID SUBSTITUTIONS IN 2 RESIDUES OF BETA POLYPEPTIDE-CHAIN, FEBS LETTERS 58: 149 (1975). · doi:10.1016/0014-5793(75)80246-8
- GUIDON G THESIS U RENNES (1978).
- KRETZSCHMAR, H. A., DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY 5: 315 (1986).
- LANGDOWN, J.V., A NEW DOUBLY SUBSTITUTED SICKLING HEMOGLOBIN - HBS-OMAN, BRITISH JOURNAL OF HAEMATOLOGY 71: 443 (1989). · doi:10.1111/j.1365-2141.1989.tb04304.x
- MAY, W.W., CREUTZFELDT-JAKOB DISEASE .2. CLINICAL PATHOLOGIC AND GENETIC STUDY OF A FAMILY, ARCHIVES OF NEUROLOGY 19: 137 (1968). · doi:10.1001/archneur.1968.00480020023002
- MOOPENN, W.F., HEMOGLOBIN-S TRAVIS - SICKLING HEMOGLOBIN WITH 2 AMINO-ACID SUBSTITUTION [BETA6(A3)GLUTAMIC ACID-] VALINE AND BETA-142 (H20) ALANINE-]VALINE], EUROPEAN JOURNAL OF BIOCHEMISTRY 77: 561 (1977). · doi:10.1111/j.1432-1033.1977.tb11699.x
- TANAKA, M.T., ACTA NEUROL SCAND 85: 327 (1992).
- YSOHIDA, K, ANN NEUROL 31: 328 (1992). · doi:10.1002/ana.410310316
Cited by
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Telling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., Mastrianni, J., Lugaresi, E., Gambetti, P., & Prusiner, S. B. (1996) · Science · doi:10.1126/science.274.5295.2079 · Cited by 865
Self-citationMolecular basis of phenotypic variability in sporadc creudeldt‐jakob disease
Parchi, P., Castellani, R., Capellari, S., Ghetti, B., Young, K., Chen, S. G., Farlow, M., Dickson, D. W., Sima, A. A. F., Trojanowski, J. Q., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390613 · Cited by 864
Self-citationBrown, P., Gibbs, C. J., Rodgers‐Johnson, P., Asher, D. M., Sulima, M. P., Bacote, A., Goldfarb, L. G., & Gajdusek, D. C. (1994) · Annals of Neurology · doi:10.1002/ana.410350504 · Cited by 817
Self-citationBessen, R. A., & Marsh, R. F. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.7859-7868.1994 · Cited by 665
Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
Physiology of the prion protein
Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008) · Physiological Reviews · doi:10.1152/physrev.00007.2007 · Cited by 617
Sporadic and familial CJD: classification and characterisation
Gambetti, P., Kong, Q., Zou, W., Parchi, P., & Chen, S. G. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.213 · Cited by 569
Self-citationPATHOLOGIC CONFORMATIONS OF PRION PROTEINS
Cohen, F. E., & Prusiner, S. B. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.793 · Cited by 533
Structural Clues to Prion Replication
Cohen, F. E., Pan, K.-M., Huang, Z., Baldwin, M., Fletterick, R. J., & Prusiner, S. B. (1994) · Science · doi:10.1126/science.7909169 · Cited by 468
James, T. L., Liu, H., Ulyanov, N. B., Farr-Jones, S., Zhang, H., Donne, D. G., Kaneko, K., Groth, D., Mehlhorn, I., Prusiner, S. B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10086 · Cited by 452
Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes
Rutland, P., Pulleyn, L. J., Reardon, W., Baraitser, M., Hayward, R., Jones, B., Malcolm, S., Winter, R. M., Oldridge, M., Slaney, S. F., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-173 · Cited by 451
Genetic prion disease: the EUROCJD experience
Kovács, G. G., Puopolo, M., Ladogana, A., Pocchiari, M., Budka, H., van Duijn, C., Collins, S. J., Boyd, A., Giulivi, A., Coulthart, M., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-0020-1 · Cited by 450
Quantifying prion disease penetrance using large population control cohorts
Minikel, E. V., Vallabh, S. M., Lek, M., Estrada, K., Samocha, K. E., Sathirapongsasuti, J. F., McLean, C. Y., Tung, J. Y., Yu, L. P. C., Gambetti, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5169 · Cited by 442
Self-citationBelt, P. B. G. M., Muileman, I. H., Schreuder, B. E. C., Bos-de Ruijter, J., Gielkens, A. L. J., & Smits, M. A. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-3-509 · Cited by 436
Goldmann, W., Hunter, N., Smith, G., Foster, J., & Hope, J. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-5-989 · Cited by 431
Budka, H., Aguzzi, A., Brown, P., Brucher, J., Bugiani, O., Gullotta, F., Haltia, M., Hauw, J., Ironside, J. W., Jellinger, K., et al. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00625.x · Cited by 428
Self-citationThe Prion's Elusive Reason for Being
Aguzzi, A., Baumann, F., & Bremer, J. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125620 · Cited by 418
A clinicopathological approach to the diagnosis of dementia
Elahi, F. M., & Miller, B. L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.96 · Cited by 412
Cuppens, H., Lin, W., Jaspers, M., Costes, B., Teng, H., Vankeerberghen, A., Jorissen, M., Droogmans, G., Reynaert, I., Goossens, M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci639 · Cited by 397
Prusiner, S. B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00171.x · Cited by 392
Sporadic human prion diseases: molecular insights and diagnosis
Puoti, G., Bizzi, A., Forloni, G., Safar, J. G., Tagliavini, F., & Gambetti, P. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70063-7 · Cited by 365
Self-citationFamilial and sporadic fatal insomnia
Montagna, P., Gambetti, P., Cortelli, P., & Lugaresi, E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00323-5 · Cited by 354
Self-citationThe Methionine-aromatic Motif Plays a Unique Role in Stabilizing Protein Structure
Valley, C. C., Cembran, A., Perlmutter, J. D., Lewis, A. K., Labello, N. P., Gao, J., & Sachs, J. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374504 · Cited by 345
Genetic Classification of Primary Neurodegenerative Disease
Hardy, J., & Gwinn-Hardy, K. (1998) · Science · doi:10.1126/science.282.5391.1075 · Cited by 343
Transmissible spongiform encephalopathies
Collins, S. J., Lawson, V. A., & Masters, C. L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15171-9 · Cited by 339
Monari, L., Chen, S. G., Brown, P., Parchi, P., Petersen, R. B., Mikol, J., Gray, F., Cortelli, P., Montagna, P., & Ghetti, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2839 · Cited by 334
Self-citationGenetic influence on the structural variations of the abnormal prion protein
Parchi, P., Zou, W., Wang, W., Brown, P., Capellari, S., Ghetti, B., Kopp, N., Schulz-Schaeffer, W. J., Kretzschmar, H. A., Head, M. W., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10168 · Cited by 330
Self-citationPrusiner, S. B., & Hsiao, K. K. (1994) · Annals of Neurology · doi:10.1002/ana.410350404 · Cited by 328
Mead, S. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201544 · Cited by 325
New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests
Zeidler, M., Stewart, G., Barraclough, C., Bateman, D., Bates, D., Burn, D., Colchester, A., Durward, W., Fletcher, N., Hawkins, S., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07472-2 · Cited by 290
Molecular biology and pathogenesis of prion diseases
PRUSINER, S. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10063-3 · Cited by 278
Elimination of prions by branched polyamines and implications for therapeutics
Supattapone, S., Nguyen, H.-O. B., Cohen, F. E., Prusiner, S. B., & Scott, M. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14529 · Cited by 259
Mutations of the Prion Protein Gene
Kovács, G. G., Trabattoni, G., Hainfellner, J. A., Ironside, J. W., Knight, R. S. G., & Budka, H. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0896-9 · Cited by 259
Telling, G. C., Haga, T., Torchia, M., Tremblay, P., DeArmond, S. J., & Prusiner, S. B. (1996) · Genes & Development · doi:10.1101/gad.10.14.1736 · Cited by 258
Phenotype-genotype studies in kuru: Implications for new variant Creutzfeldt–Jakob disease
Cervenáková, L., Goldfarb, L. G., Garruto, R., Lee, H.-S., Gajdusek, D. C., & Brown, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13239 · Cited by 160
Self-citationIncreased Susceptibility to Kuru of Carriers of the PRNP 129 Methionine/Methionine Genotype
Lee, H., Brown, P., Cervenáková, L., Garruto, R. M., Alpers, M. P., Gajdusek, D. C., & Goldfarb, L. G. (2001) · The Journal of Infectious Diseases · doi:10.1086/317935 · Cited by 140
Self-citationKim, M.-O., Takada, L. T., Wong, K., Forner, S. A., & Geschwind, M. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033134 · Cited by 130
Identifying modifier genes of monogenic disease: strategies and difficulties
Génin, E., Feingold, J., & Clerget-Darpoux, F. (2008) · Human Genetics · doi:10.1007/s00439-008-0560-2 · Cited by 126
Familial spongiform encephalopathy associated with a novel prion protein gene mutation
Nitrini, R., Rosemberg, S., Passos‐Bueno, M. R., da Silva, L. S. T., Iughetti, P., Papadopoulos, M., Carrilho, P. M., Caramelli, P., Albrecht, S., Zatz, M., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410420203 · Cited by 106
Self-citationBouybayoune, I., Mantovani, S., Del Gallo, F., Bertani, I., Restelli, E., Comerio, L., Tapella, L., Baracchi, F., Fernández-Borges, N., Mangieri, M., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004796 · Cited by 81
“A typical example is the prion disease linked to the substitution of aspartic acid (D) to asparagine (N) at codon 178, which, depending on the aminoacid encoded at polymorphic site 129, segregates with either FFI (D178N/M129), primarily characterized by severe sleep disorders and autonomic dysfunction, or CJD(178) (D1…”
BackgroundKuru: Genes, Cannibals and Neuropathology
Liberski, P. P., Sikorska, B., Lindenbaum, S., Goldfarb, L. G., McLean, C., Hainfellner, J. A., & Brown, P. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182444efd · Cited by 59
“The methionine/valine (Met/ Val) variation at position 129 does not by itself cause the disease but dramatically influences the phenotype resulting from other PRNPmutations (23) and influences susceptibility/ resistance to kuru and iatrogenic and sporadic forms of CJD (24Y26).”
BackgroundSelf-citationUnderstanding the natural variability of prion diseases
Geissen, M., Krasemann, S., Matschke, J., & Glatzel, M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.041 · Cited by 24
Deletion of the prion gene Prnp affects offensive aggression in mice
Büdefeld, T., Majer, A., Jerin, A., & Majdic, G. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.03.006 · Cited by 11
Metadata
- Authors
- Goldfarb, L. G., Petersen, R. B., Tabaton, M., Brown, P., LeBlanc, A. C., Montagna, P., Cortelli, P., Julien, J., Vital, C., Pendelbury, W. W., Haltia, M., Wills, P. R., Hauw, J. J., McKeever, P. E., Monari, L., Schrank, B., Swergold, G. D., Autilio-Gambetti, L., Gajdusek, D. C., Lugaresi, E., & Gambetti, P.
- Venue
- Science
- Published
- 1992-10-30
- Volume
- 258
- Issue
- 5083
- Pages
- 806-808
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2048041842
- Cited by
- 716
- References
- 29
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.